COLE G BRADLEY 1337798 Data last updated 2024-11-27 07:14:18 -0600 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-29 | 2024-05-25 | 2024-05-25 | 4 | Cole G Bradley | DIRECTOR | acq | 8636.0 | 64.98 | 3.13 | 0.0 | Direct | Common Stock | CASTLE BIOSCIENCES INC | code M | 13291.0 | 27.61 (CSTL) |
| 2024-06-07 | 2024-06-05 | 2024-06-06 | 4 | Cole G Bradley | DIRECTOR | acq | 4373.0 | 46.66 | 1.08 | 0.0 | Direct | Class A Common Share | KINIKSA PHARMACEUTICALS, LTD. | code M | 9373.0 | 40.31 (KNSA) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-28 | 2024-05-23 | 2024-05-23 | 4 | Cole G Bradley | DIRECTOR | acq | 8673.0 | 100.0 | 3.14 | 0.0 | Direct | Restricted Stock Units | CASTLE BIOSCIENCES INC | code A | 8673.0 | 27.61 (CSTL) |
| 2024-05-29 | 2024-05-25 | 2024-05-25 | 4 | Cole G Bradley | DIRECTOR | dsp | 8636.0 | 100.0 | 3.13 | 0.0 | Direct | Restricted Stock Units | CASTLE BIOSCIENCES INC | code M | 0.0 | 27.61 (CSTL) |
| 2024-06-07 | 2024-06-05 | 2024-06-05 | 4 | Cole G Bradley | DIRECTOR | acq | 19040.0 | 100.0 | 4.72 | 19.71 | Direct | Share Option | KINIKSA PHARMACEUTICALS, LTD. | code A | 19040.0 | 40.31 (KNSA) |
| 2024-06-07 | 2024-06-05 | 2024-06-06 | 4 | Cole G Bradley | DIRECTOR | dsp | 4373.0 | 100.0 | 1.08 | 0.0 | Direct | Restricted Share Units | KINIKSA PHARMACEUTICALS, LTD. | code M | 0.0 | 40.31 (KNSA) |
| 2024-06-07 | 2024-06-05 | 2024-06-05 | 4 | Cole G Bradley | DIRECTOR | acq | 3173.0 | 100.0 | 0.79 | 0.0 | Direct | Restricted Share Units | KINIKSA PHARMACEUTICALS, LTD. | code A | 3173.0 | 40.31 (KNSA) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)